Core-genome-mediated promising alternative drug and multi-epitope vaccine targets prioritization against infectious Clostridium difficile
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0293731 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Sara Aiman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Environmental and Life Sciences, Beijing University of Technology, Beijing, China. Hauptthemen laut MEDLINE: Clostridioides difficile. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prevention of Clostridium difficile infection is challenging worldwide owing to its high morbidity and mortality rates. C . difficile is currently being classified as an urgent threat by the CDC. Devising a new therapeutic strategy become indispensable against C . difficile infection due to its high rates of reinfection and increasing antimicrobial resistance. The current study is based on core proteome data of C . difficile to identify promising vaccine and drug candidates. Immunoinformatics and vaccinomics approaches were employed to construct multi-epitope-based chimeric vaccine constructs from top-ranked T- and B-cell epitopes. The efficacy of the designed vaccine was assessed by immunological analysis, immune receptor binding potential and immune simulation analyses. Additionally, subtractive proteomics and druggability analyses prioritized several promising and alternative drug targets against C . difficile . These include FMN-dependent nitroreductase which was prioritized for pharmacophore-based virtual screening of druggable molecule databases to predict potent inhibitors. A MolPort-001-785-965 druggable molecule was found to exhibit significant binding affinity with the conserved residues of FMN-dependent nitroreductase. The experimental validation of the therapeutic targets prioritized in the current study may worthy to identify new strategies to combat the drug-resistant C . difficile infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Environmental and Life Sciences, Beijing University of Technology, Beijing, China.
- Department of Biochemistry, Abdul Wali Khan University Mardan, Mardan, Pakistan.
- Department of Biotechnology, Abdul Wali Khan University Mardan, Mardan, KP, Pakistan.
- School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, Hong Kong.
ORCID-Profile: Yasir Ali
Zitieren
APA
Aiman, S., Farooq, Q. U. A., Han, Z., Aslam, M., Zhang, J., Khan, A., Ahmad, A., Li, C., & Ali, Y. (2024). Core-genome-mediated promising alternative drug and multi-epitope vaccine targets prioritization against infectious Clostridium difficile. PLOS ONE. https://doi.org/10.1371/journal.pone.0293731
Vancouver
Aiman S, Farooq QUA, Han Z, Aslam M, Zhang J, Khan A, et al. Core-genome-mediated promising alternative drug and multi-epitope vaccine targets prioritization against infectious Clostridium difficile. PLOS ONE. 2024. doi:10.1371/journal.pone.0293731
BibTeX
@article{Aiman2024,
author = {Aiman, Sara and Farooq, Qurrat Ul Ain and Han, Zhongjie and Aslam, Muneeba and Zhang, Jilong and Khan, Asifullah and Ahmad, Abbas and Li, Chunhua and Ali, Yasir},
title = {Core-genome-mediated promising alternative drug and multi-epitope vaccine targets prioritization against infectious Clostridium difficile},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0293731}
}
EUVIMED